Richard Anderson
Stock Analyst at Wedbush
(3.75)
# 640
Out of 4,829 analysts
140
Total ratings
60.27%
Success rate
3.83%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HR Healthcare Realty Trust | Maintains: Neutral | $18 → $16 | $15.35 | +4.23% | 9 | May 5, 2025 | |
| DOC Healthpeak Properties | Maintains: Outperform | $24 → $22 | $17.47 | +25.93% | 5 | Apr 28, 2025 | |
| SAFE Safehold | Reiterates: Neutral | $20 | $15.35 | +30.29% | 5 | Apr 1, 2025 | |
| NHI National Health Investors | Reiterates: Outperform | $88 | $76.77 | +14.63% | 4 | Mar 17, 2025 | |
| CTRE CareTrust REIT | Reiterates: Underperform | $26 | $29.15 | -10.81% | 3 | Mar 14, 2025 | |
| STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $10.00 | +40.00% | 2 | Mar 5, 2025 | |
| VTR Ventas | Maintains: Outperform | $69 → $78 | $66.01 | +18.16% | 7 | Feb 14, 2025 | |
| WELL Welltower | Upgrades: Outperform | $145 → $167 | $149.18 | +11.95% | 5 | Feb 14, 2025 | |
| UMH UMH Properties | Reiterates: Neutral | $20 | $17.28 | +15.74% | 4 | Jan 13, 2025 | |
| DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $14.51 | +44.73% | 2 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $81 → $70 | $64.21 | +9.02% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $31.86 | +3.58% | 3 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $61.38 | +17.30% | 1 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $74.07 | +48.51% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $167.96 | +24.43% | 5 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $35.90 | +11.42% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $117.98 | +11.04% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $69.94 | +7.23% | 5 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $282.69 | +6.48% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $42.29 | +15.87% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $34.61 | +30.02% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $26.78 | +23.23% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $163.02 | +12.87% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $14.77 | +48.95% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $10.38 | +63.78% | 3 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $46.89 | +8.77% | 2 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $49.53 | -1.07% | 5 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $34.18 | +31.66% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $57.14 | +17.26% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $2.27 | +230.40% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $97.11 | -3.20% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $9.74 | +43.74% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $18.19 | -12.04% | 5 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $35.86 | -5.19% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $205.53 | -12.91% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.55 | - | 2 | May 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.87 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.19 | - | 2 | Jul 10, 2017 |
Healthcare Realty Trust
May 5, 2025
Maintains: Neutral
Price Target: $18 → $16
Current: $15.35
Upside: +4.23%
Healthpeak Properties
Apr 28, 2025
Maintains: Outperform
Price Target: $24 → $22
Current: $17.47
Upside: +25.93%
Safehold
Apr 1, 2025
Reiterates: Neutral
Price Target: $20
Current: $15.35
Upside: +30.29%
National Health Investors
Mar 17, 2025
Reiterates: Outperform
Price Target: $88
Current: $76.77
Upside: +14.63%
CareTrust REIT
Mar 14, 2025
Reiterates: Underperform
Price Target: $26
Current: $29.15
Upside: -10.81%
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $10.00
Upside: +40.00%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $66.01
Upside: +18.16%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $149.18
Upside: +11.95%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $17.28
Upside: +15.74%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $14.51
Upside: +44.73%
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $64.21
Upside: +9.02%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $31.86
Upside: +3.58%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $61.38
Upside: +17.30%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $74.07
Upside: +48.51%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $167.96
Upside: +24.43%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $35.90
Upside: +11.42%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $117.98
Upside: +11.04%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $69.94
Upside: +7.23%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $282.69
Upside: +6.48%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $42.29
Upside: +15.87%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $34.61
Upside: +30.02%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $26.78
Upside: +23.23%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $163.02
Upside: +12.87%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $14.77
Upside: +48.95%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $10.38
Upside: +63.78%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $46.89
Upside: +8.77%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $49.53
Upside: -1.07%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $34.18
Upside: +31.66%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $57.14
Upside: +17.26%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $2.27
Upside: +230.40%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $97.11
Upside: -3.20%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $9.74
Upside: +43.74%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $18.19
Upside: -12.04%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $35.86
Upside: -5.19%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $205.53
Upside: -12.91%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $4.55
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $7.87
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.19
Upside: -